American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

GH Lyman, M Carrier, C Ay, M Di Nisio… - Blood …, 2021 - ashpublications.org
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Natural coumarins: exploring the pharmacological complexity and underlying molecular mechanisms

J Sharifi-Rad, N Cruz-Martins… - Oxidative Medicine …, 2021 - Wiley Online Library
Coumarins belong to the benzopyrone family commonly found in many medicinal plants.
Natural coumarins demonstrated a wide spectrum of pharmacological activities, including …

Coumarin heterocyclic derivatives: chemical synthesis and biological activity

FG Medina, JG Marrero, M Macías-Alonso… - Natural product …, 2015 - pubs.rsc.org
Coumarin heterocyclic derivatives: chemical synthesis and biological activity - Natural Product
Reports (RSC Publishing) DOI:10.1039/C4NP00162A Royal Society of Chemistry View PDF …

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the …

Authors/Task Force Members, A Torbicki… - European heart …, 2008 - academic.oup.com
Document Reviewers: Jose-Luis Zamorano,(CPG Review Coordinator)(Spain), Felicita
Andreotti (Italy), Michael Ascherman (Czech Republic), George Athanassopoulos (Greece) …

Lysis of tumor cells by natural killer cells in mice is impeded by platelets

B Nieswandt, M Hafner, B Echtenacher, DN Männel - Cancer research, 1999 - AACR
Natural killer (NK) cells provide effective antitumoral activity in the blood stream of mice,
leading to reduced metastasis. There are, however, tumor cells that metastasize despite the …

Venous thromboembolism and cancer: risks and outcomes

AYY Lee, MN Levine - Circulation, 2003 - Am Heart Assoc
Cancer and its treatments are well-recognized risk factors for venous thromboembolism
(VTE). Evidence suggests that the absolute risk depends on the tumor type, the stage or …

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer

GH Lyman, AA Khorana, A Falanga… - Journal of clinical …, 2007 - ascopubs.org
Purpose To develop guideline recommendations for the use of anticoagulation in the
prevention and treatment of venous thromboembolism (VTE) in patients with cancer …

Cancer and venous thromboembolism

P Prandoni, A Falanga, A Piccioli - The lancet oncology, 2005 - thelancet.com
Venous thromboembolism occurs commonly in patients with cancer. The pathogenetic
mechanisms of thrombosis involve a complex interaction between tumour cells, the …

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

L Borsig, R Wong, J Feramisco… - Proceedings of the …, 2001 - National Acad Sciences
Independent studies indicate that expression of sialylated fucosylated mucins by human
carcinomas portends a poor prognosis because of enhanced metastatic spread of tumor …

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS)

AK Kakkar, MN Levine, Z Kadziola… - Journal of Clinical …, 2004 - ascopubs.org
Purpose In experimental systems, interference with coagulation can affect tumor biology.
Furthermore, it has been suggested that low molecular weight heparin therapy may prolong …